Document:

Amend. #3 dated 04/17/2008 to Consulting Agmt dated 04/16/2004

 EXHIBIT 10.106 
 AMENDMENT NO. 3 TO CONSULTING AGREEMENT 
 This AMENDMENT NO. 3 TO CONSULTING AGREEMENT (the
“Amendment No. 3”) is made and entered into as of April 17, 2008, by and between Cortex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Gary D. Tollefson, M.D., Ph.D., an individual
residing in the State of Indiana (“Consultant”). 
 RECITALS 
 A. The Company currently engages Consultant pursuant to the terms and conditions of that certain Consulting Agreement dated April 16, 2004 (the
“Consulting Agreement”) and the Amendment to Consulting Agreement dated May 16, 2006 and the Amendment No. 2 to Consulting Agreement dated April 16, 2007. 
 B. The Company and Consultant desire to amend the Consulting Agreement to extend the term set forth therein, as provided in greater detail below.

 NOW, THEREFORE, in consideration of the mutual agreements and covenants hereinafter set forth and for other valuable consideration, the
Company and Consultant hereby agree as follows: 
 AGREEMENT 
 1. Definitions. Unless otherwise defined, capitalized terms used herein shall have the meanings assigned to them in the Consulting Agreement.

 2. Term. Section 2(a) of the Consulting Agreement is hereby amended and restated in its entirety to read as follows:

 “Term. Consultant’s engagement with the Company shall commence on the Effective Date and shall continue for a period of
sixty (60) months thereafter, subject to earlier termination as hereinafter provided.” 
 3. Continuing Force and Effect.
Except as herein expressly amended, modified and/or supplemented, all terms, covenants and provisions of the Consulting Agreement and Amendment to Consulting Agreement dated May 16, 2006 are and shall remain in full force and effect and all
references therein to such Consulting Agreement shall henceforth refer to the Consulting Agreement as amended by this Amendment No. 3. This Amendment No. 3 shall be deemed incorporated into, and a part of, the Consulting Agreement.

 [Remainder of Page Intentionally Left Blank; Signature Page Follows] 

 IN WITNESS WHEREOF, this Amendment No. 3 has been made and entered into as of the date and year
first above written. 
  

	
	 “Company”

	
	Cortex Pharmaceuticals, Inc.
	
	 /s/ Roger G. Stoll

	Roger G. Stoll, Ph.D.
	President and Chief Executive Officer
	
	“Consultant”
	
	 /s/ Gary D. Tollefson

	Gary D. Tollefson, M.D., Ph.D.Severance Agmt dated 05/02/2008 between Company and Steven Johnson

 EXHIBIT 10.107 
  

			
	

	 	Roger G. Stoll, Ph.D.
	 	Chairman, President, & Chief Executive Officer
	 	Cortex Pharmaceuticals, Inc.
	 	15231 Barranca Parkway
	 	Irvine, CA 92618
	 	Telephone: (949) 727-3157, ext. 101
	 	Facsimile: (949) 727-3657
	 	rstoll@cortexpharm.com

 May 2, 2008 
 Steven A. Johnson, Ph.D. 
 c/o Cortex Pharmaceuticals, Inc. 
 15241 Barranca Parkway 
 Irvine, California 92618 
 Dear
Steve: 
 The purpose of this letter is to document the terms and conditions of the severance package to which you shall be entitled in certain circumstances
should your employment with Cortex Pharmaceuticals, Inc. (the “Company”) terminate and also to provide for acceleration of vesting of your stock options upon a sale of the Company. Please understand that the Company is an at-will employer,
and your employment is not for any specific term. You are free to resign, and the Company is free to terminate your employment at any time, with or without cause. 
 In the event of termination of your employment by the Company without cause in connection with, or within six (6) months following a “Change In Control” (as defined in the 2006 Stock Incentive Plan) you shall be entitled to
termination pay equal to twelve months of your base salary. The payments shall be in lieu of all damages and other compensation to which you may be entitled, under any employment agreement or otherwise, by reason of termination of your employment
and shall also be in lieu of further salary payments to you for periods subsequent to the termination of your employment. The payment shall not be considered compensation for any benefit calculation or other benefit plan maintained by the Company.
The payments will be paid to you in a lump sum, net of all applicable withholding taxes, within 30 days after your date of termination. You will also receive payment for all unpaid, paid time off days that you have accrued through the date of your
termination. In the event you receive payment, you shall also be entitled to continue to participate in the Company’s employee benefit program, including medical, dental, and prescription coverage for a period of twelve (12) months, to the
extent permitted by the Company’s insurance provider. The related premiums for such benefits will be paid by the Company. Upon a Change of Control, all stock options then held by you shall vest concurrently with such Change of Control.

 To confirm that you agree to the terms stated in this letter, please sign and date the enclosed copy of this letter and
return it to me no later than May 2, 2008. 
  

	
	 Very truly yours,

	
	 /s/ Roger G. Stoll

	Roger G. Stoll, Ph.D.
	Chairman, President, and Chief Executive Officer

 I agree to the terms stated in this letter. 
  

	
	 /s/ Steven A. Johnson

	Steven A. Johnson, Ph.D.
	
	Dated: 02 May, 2008PERFORMANCE SHARE AWARD AGREEMENT

 Exhibit 10.1 
 OWENS & MINOR, INC. 
 PERFORMANCE SHARE AWARD AGREEMENT 
 THIS PERFORMANCE SHARE AWARD AGREEMENT (“Agreement”) dated as of
                     between Owens & Minor, Inc., a Virginia corporation (the “Company”), and
                     (“Participant”) is made pursuant to and subject to the provisions of the Company's 2005 Stock Incentive Plan
(the “Plan”). All terms used in this Agreement that are not otherwise defined shall have the same meanings given to them in the Plan. 
 1. Grant of Performance Share Award. In accordance with the Plan, on                      (the “Date of
Grant”), the Company granted to the Participant, subject to the terms and conditions of the Plan and the terms and conditions set forth in this Agreement,
                     Performance Shares, subject to adjustment as provided in Section 2 (the “Performance Shares”). The
Participant will earn the Performance Shares to the extent that the requirements of Section 2 are satisfied. The Company will issue shares of Common Stock in accordance with Section 3 in settlement of the Performance Shares, if any, that
the Participant earns in accordance with Section 2, which shares of Common Stock (the “Restricted Stock”) will be further subject to the vesting and forfeiture provisions described in Section 4 (except as otherwise specifically
provided in Section 3(b)). 
 2. Earning Performance Shares. This Section 2 determines the number of Performance
Shares that the Participant earns under this Agreement. 
 (a) Performance Criteria. The Participant will earn Performance Shares based
on the Company’s Operating Earnings (defined below) for calendar year 200   as follows: 
  

					
	 200   Operating Earnings
	  	Performance Shares Earned
	 $            
	    	 (Threshold)
	  	_______
	 $            
	    	 (Target)
	  	_______
	 $            
	    	 (Maximum)
	  	_______

 If the Company’s Operating Earnings for calendar year 200   are greater than
the Threshold but less than the Target, then the additional number of Performance Shares earned by the Participant in excess of              Performance Shares will be determined
based on a straight line interpolation of the Operating Earnings in excess of the Threshold. If the Company’s Operating Earnings for calendar year 200   are greater than the Target but less than the Maximum, then the additional
number of Performance Shares earned by the Participant in excess of              Performance Shares will be determined based on a straight line interpolation of the Operating
Earnings in excess of the Target. Operating Earnings shall be defined as the “operating earnings” presented in the Company’s consolidated audited financial statements for the year ended December 31, 200  , which,
for purposes of this Agreement, will be adjusted to exclude unusual and/or non-recurring items, including but not limited to, the effect of accounting and/or tax changes; tangible and intangible asset impairment charges; fees, expenses and charges
associated with debt and/or equity financing transactions and merger and acquisition activity (including sale of a business unit or its assets); gains/losses from asset sales not made in the ordinary course of business; pension plan gains/losses;
and 

  

 17 

 
material litigation or insurance settlements. Adjustments to Operating Earnings for purposes of determining the number of Performance Shares earned shall be
taken into account only to the extent that they are separately identified or quantified in the Company’s consolidated audited financial statements, the notes to the consolidated financial statements, “Management’s Discussion and
Analysis” in the annual report or in other Company filings with the Securities and Exchange Commission. In addition to and notwithstanding the foregoing, the Committee may make any adjustments in its discretion that would reduce Operating
Earnings for purposes of determining the number of Performance shares earned, such as for example, the exclusion of operating earnings from acquisitions, mergers or divestitures. 
 (b) Effect of Termination During 200   or Prior to Issuance of Restricted Stock. Except as provided in subparagraphs (c) and (d), no
Performance Shares will be earned if the Participant’s employment with, and service to, the Company and its Affiliates terminates or is terminated before January 1, 200   or the date on which Restricted Stock is issued as
provided in Section 3(b). 
 (c) Death or Disability During 200  . This subparagraph (c) applies if the
Participant’s employment with, and service to, the Company and its Affiliates terminates before January 1, 200  , on account of the Participant’s death or permanent and total disability (as defined in
Section 22(e)(3) of the Code). In the event of the Participant’s death prior to January 1, 200  , the number of Performance Shares earned by the Participant shall equal the number determined in accordance with
subparagraph (a). In the event the Participant’s employment terminates before January 1, 200   due to permanent and total disability, the number of Performance Shares earned by the Participant shall equal the number
determined in accordance with subparagraph (a) multiplied by a fraction. The numerator of the fraction shall be the number of whole months that the Participant was employed by, or providing services to, the Company or an Affiliate during
200   (including any period that the Participant was absent from work for illness, injury or short term disability prior to termination of employment) and the denominator shall be 12. 
 (d) Change in Control. The Participant will earn the number of Performance Shares designated for Target Operating Earnings if there is a Change in
Control before January 1, 200  . 
 3. Settlement of Performance Shares. The Performance Shares will be
settled in accordance with this Section 3. 
 (a) Committee Certification. As soon as practicable after 200  
(but no later than March 15, 200  ), the Committee will determine the number of Performance Shares that are earned under the provisions of Section 2. The Committee’s determination shall be set forth in writing, as
part of the minutes of a meeting of the Committee, by unanimous consent or otherwise. Notwithstanding the preceding sentences, a written determination of the Committee shall not be required in the case of Performance Shares that are earned pursuant
to the provisions of Section 2(d). 
  

 18 

 (b) Issuance of Restricted Stock. As soon as practicable after the Committee’s certification
under subparagraph (a) (but no later than March 15, 200  ), the Committee shall issue shares of Restricted Stock under the Plan in settlement of the Performance Shares earned by the Participant. The number of shares of
Restricted Stock issued shall equal the number of Performance Shares earned by the Participant. Notwithstanding the preceding sentences, (i) if the Performance Shares are earned pursuant to the provisions of Section 2(c), such Performance
Shares shall be settled in shares of Common Stock that are not subject to the restrictions set forth in Section 4 and (ii) if the Performance Shares are earned pursuant to the provisions of Section 2(d), the number of shares of
Restricted Stock indicated in Section 2(d) shall be issued to the Participant on the Control Change Date, and such shares of Restricted Stock shall otherwise be treated as provided in Section 4(c)(vi). 
 (c) Registration, etc. Shares of Restricted Stock issued in settlement of the Performance Shares shall be registered in the name of the Participant
on the stock transfer books of the Company but shall be held by the Company (or its transfer agent) during the Restricted Period (defined below). The Company’s Secretary and its General Counsel shall serve as attorney-in-fact for Participant
during the Restricted Period with full power and authority in Participant’s name to assign and convey to the Company any shares of Restricted Stock that Participant forfeits under Section 4(c). Each certificate representing shares of
Restricted Stock may bear a legend referring to the risk of forfeiture of the shares and stating that such shares are nontransferable until all restrictions have been satisfied and the legend has been removed. 
 (d) Dividends. Upon issuance of shares of Restricted Stock in settlement of the Performance Shares earned by the Participant, the Company shall pay
Participant in cash the amount of any dividends that would have been paid on the Performance Shares prior to settlement if the Performance Shares had been actual shares of Restricted Stock outstanding during 200_. 
 4. Terms of Restricted Stock. The shares of Restricted Stock issued in settlement of the Performance Shares are subject to the following
terms and conditions: 
 (a) Restricted Period. Until
                     (the “Restricted Period”) or the lapse of restrictions as provided in subparagraph (c) hereof, the
Restricted Stock shall be subject to the following restrictions: 
 (i) Participant shall not be entitled to receive the certificate or
certificates evidencing the Restricted Stock; 
 (ii) Shares of Restricted Stock may not be sold, transferred, assigned, pledged, conveyed,
hypothecated or otherwise disposed of; and 
 (iii) Shares of Restricted Stock may be forfeited immediately as provided in subparagraph
(c) hereof. 
 (b) Distribution of Restricted Stock. If Participant remains in the continuous employment of the Company or an
Affiliate during the entire Restricted Period and otherwise does not forfeit such shares pursuant to subparagraph (c) hereof, all restrictions applicable to 

  

 19 

 
the shares of Restricted Stock shall lapse upon expiration of the Restricted Period and a certificate or certificates representing the shares of Common Stock
that were granted to Participant in the form of shares of Restricted Stock shall be delivered to Participant. 
 (c) Lapse of Restrictions
or Forfeiture. 
  

	 	(i)	Death. If Participant’s employment with the Company and its Affiliates is terminated before the expiration of the Restricted Period by reason of Participant’s
death, all restrictions applicable to the shares of Restricted Stock shall immediately lapse on the date of Participant’s death and the certificate or certificates representing the shares of Common Stock shall be delivered to Participant’s
estate. 

  

	 	(ii)	Disability. If Participant’s employment with the Company and its Affiliates is terminated before the expiration of the Restricted Period by reason of “total and
permanent disability” (as such term is defined in Section 22(e)(3) of the Code), all restrictions on a pro rata number of shares of Restricted Stock shall lapse. The “pro rata number” shall be the number of shares of Restricted
Stock multiplied by a fraction, the numerator of which is the number of months (including a fractional month) of Participant’s employment after the Date of Grant and the denominator of which is 36. The certificate or certificates representing
the shares of Common Stock upon which the restrictions have lapsed shall be delivered to Participant. 

  

	 	(iii)	Retirement. If Participant’s employment with the Company and its Affiliates is terminated before the expiration of the Restricted Period by reason of retirement (defined
below), all shares of Restricted Stock shall be forfeited immediately and all rights of Participant to such shares shall terminate immediately without further obligation on the part of the Company. Notwithstanding the foregoing, if
Participant’s service to the Company or an Affiliate continues from and after the date of retirement through (i) membership on the Board, (ii) a written consulting services arrangement with the Company or an Affiliate or (iii) at
the Company’s discretion, a written confidentiality and non-solicitation agreement with the Company (“Post-Retirement Service”), shares of Restricted Stock shall not be forfeited but shall continue to be held by the Company until the
earlier of (i) the end of the Restricted Period at which time such shares shall be delivered to the Participant or (ii) the date Participant ceases to provide Post-Retirement Service at which time such shares shall be forfeited. For
purposes of this subparagraph 4(c)(iii), retirement shall mean severance from the employment of the Company and its Affiliates (i) at or after the attainment of age 55 and after completing a number of years of service (the total years of
service credited to Participant for purposes of determining vested or nontransferable interest in a defined benefit pension plan maintained by the Company or an Affiliate which satisfies the requirements of Section 401(a) of the Code) that,
when added to Participant’s age at the time of severance from employment, equals at least 65 or (ii) at or after the attainment of age 65. 

  

	 	(iv)	Termination of Employment by Company or Affiliate. 

  

	 	(a)	 With Cause. If the Company or an Affiliate terminates Participant’s employment with the Company and its Affiliates with “cause,” all shares of
Restricted Stock shall 

  

 20 

	 	 
be forfeited immediately and all rights of Participant to such shares shall terminate immediately without further obligation on the part of the Company. For
purposes of this Agreement, “cause” means: (i) misappropriation, theft or embezzlement of funds or property from the Company or an Affiliate or securing or attempting to secure personally any profit in connection with any transaction
entered into on behalf of the Company or an Affiliate, (ii) conviction of, or entry of a plea of “nolo contendere” with respect to, a felony which, in the reasonable opinion of the Company, is likely to cause material harm to
the Company’s or an Affiliate’s business, customer or supplier relations, financial condition or prospects, (iii) violation of the Company’s Code of Honor or any successor code of conduct; or (iv) failure to substantially
perform (other than by reason of illness or temporary disability, regardless of whether such temporary disability is or becomes a total and permanent disability (as defined in subparagraph 4(c)(ii) above), or by reason of approved leave of absence)
the duties of Participant’s job. 

  

	 	(b)	Without Cause. If Participant’s employment with the Company and its Affiliates is terminated by the Company or an Affiliate without “cause,” all restrictions
on a pro rata number of shares of Restricted Stock shall lapse. The “pro rata number” shall be the number of shares of Restricted Stock multiplied by a fraction, the numerator of which is the number of months (including a fractional month)
of Participant’s employment after the Date of Grant and the denominator of which is 36. The certificate or certificates representing the shares of Common Stock upon which the restrictions have lapsed shall be delivered to Participant.

  

	 	(v)	Termination of Employment by Participant. If Participant resigns from employment with the Company and its Affiliates before the expiration of the Restricted Period, without
regard to the reason for such resignation (other than death, disability or retirement as provided in subsections (i), (ii) and (iii) above), all of the shares of Restricted Stock shall be forfeited immediately and all rights of Participant
to such shares shall terminate immediately without further obligation on the part of the Company. 

  

	 	(vi)	Change in Control. 

  

	 	(a)	If, upon a Change in Control, (i) the Restricted Stock is assumed by, or a substitute award granted by, the surviving entity (together with its Related Entities, the
“Surviving Entity”) in the Change in Control (such assumed or substituted award to be of the same type of award as this Restricted Stock with a value as of the Control Change Date substantially equal to the value of this Restricted Stock)
and (ii) within 24 months of the Control Change Date, Participant’s employment with the Surviving Entity is terminated by the Surviving Entity without Cause (defined below) or by Participant for Good Reason (defined below), all
restrictions applicable to the shares of Restricted Stock shall immediately lapse on the date of employment termination and the certificate or certificates representing the shares of Common Stock upon which the restrictions have lapsed shall be
delivered to Participant. 

  

 21 

	 	(b)	For purposes of this subsection 4(c)(vi), “Cause” shall mean (i) the willful and continued failure by Participant to substantially perform his or her duties with the
Surviving Entity (other than any such failure resulting from Participant’s incapacity due to physical or mental illness) after a written demand for substantial performance is delivered to Participant by the Surviving Entity, which demand
specifically identifies the manner in which the Surviving Entity believes that Participant has not substantially performed his or her duties, or (ii) the willful engaging by Participant in conduct which is demonstrably and materially injurious
to the Surviving Entity, monetarily or otherwise. For purposes of this paragraph, no act, or failure to act, on Participant’s part shall be deemed “willful” unless done, or omitted to be done, not in good faith and without reasonable
belief that the action or omission was in the best interest of the Surviving Entity. 

  

	 	(c)	For purposes of this subparagraph 4(c)(vi), “Good Reason” shall have the meaning given to such term in the Executive Severance Agreement between Participant and the
Company effective January 1, 200_, as such agreement from time to time may be amended, modified, extended or replaced by a successor agreement or plan. 

  

	 	(d)	If, upon a Change in Control, the Restricted Stock is not assumed by, or a substitute award granted by, the Surviving Entity in the Change in Control as provided in subparagraph
4(c)(vi)(a) above, all restrictions applicable to the shares of Restricted Stock shall immediately lapse on the Control Change Date and the certificate or certificates representing the shares of Common Stock upon which the restrictions have lapsed
shall be delivered to Participant. 

 5. Nontransferability. The Performance Shares are nontransferable except by
will or by the laws of descent and distribution. Shares of Restricted Stock issued in settlement of the Performance Shares cannot be transferred before the Restricted Period lapses except by will or by the laws of descent and distribution.

 6. Shareholder Rights. Except as otherwise specifically provided herein, the Participant shall not have any rights as a
shareholder of the Company with respect to the Performance Shares. Upon the issuance of shares of Restricted Stock in settlement of the Performance Shares, the Participant shall have all of the rights of a shareholder of the Company with respect to
those shares, including the right to vote the shares and to receive, free of all restrictions, ordinary cash dividends. Stock received as a dividend on, or in connection with a stock split of any shares of Restricted Stock issued in settlement of
the Performance Shares shall be subject to the same vesting restrictions as the underlying shares of Restricted Stock. The Participant’s right to receive any extraordinary dividends or distributions with respect to shares of Restricted Stock
issued in settlement of the Performance Shares shall be at the sole discretion of the Committee, but in the event of any such extraordinary event, the Committee shall take action appropriate to preserve the value of, and to prevent the unintended
enhancement of value in such shares of Restricted Stock. 
 7. Withholding. The Participant shall pay the Company any amount of
taxes as may be necessary in the opinion of the Company to satisfy tax withholding required under the laws of any country, state, province, city or other jurisdiction, including but not limited to income taxes, capital gains taxes, transfer taxes,
and social security contributions. In lieu thereof, the Company shall have the right 

  

 22 

 
to retain, from the shares of Restricted Stock to be issued under Section 3, the number of shares of Restricted Stock with Fair Market Value equal to
the minimum amount required to be withheld. In any event, the Company shall have the right to deduct from all amounts paid to a Participant in cash (whether under the Plan or otherwise) any taxes required to be withheld. The Participant shall
promptly notify the Company of any election made pursuant of Section 83(b) of the Code. 
 8. No Right to Continued
Employment. The award and settlement of the Performance Shares does not give Participant any right with respect to continuance of employment by the Company or an Affiliate, nor shall it interfere in any way with the right of the Company or
an Affiliate to terminate his or her employment at any time. 
 9. Change in Capital Structure. The number of Performance
Shares and the performance criteria in Section 2 (or, after any settlement of the Performance Shares, the number of shares of Restricted Stock) shall be adjusted as the Committee determines is equitably required in the event the Company effects
one or more stock dividends, stock split-ups subdivisions or consolidations of shares, other similar changes in capitalization or such other events as are described in the Plan. 
 10. Governing Law. These Terms and Conditions and the Grant Notice shall be governed by the laws of the Commonwealth of Virginia.

 11. Conflicts. In the event of any conflict between the provisions of the Plan as in effect on the Date of Grant and the
provisions of these Terms and Conditions or the Grant Notice, the provisions of the Plan shall govern. All references herein to the Plan shall mean the plan as in effect on the Date of Grant. 
 12. Participant Bound by Plan. Participant hereby acknowledges that a copy of the Plan has been made available to him or her and agrees to
be bound by all the terms and provisions of the Plan. 
 13. Binding Effect. Subject to the limitations stated above and in the
Plan, these Terms and Conditions and the Grant Notice shall be binding upon Participant and his or her successors in interest and the successors of the Company. 
 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written. 
  

			
		 	OWENS & MINOR, INC.
		
	By:	 	  

		
		 	  

		 	Participant

  

 23

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]